NCT06581224 Implementation of a Primary Hospital Provider (PHP) Team
| NCT ID | NCT06581224 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | High-need, High-complexity |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,200 participants |
| Start Date | 2025-01-09 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,200 participants in total. It began in 2025-01-09 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pragmatic clinical trial is to learn if it is possible to implement a Primary Hospital Provider (PHP) team that aims to improve continuity of care for patients who are frequently hospitalized. The main question it aims to answer is: Are patients assigned to the PHP team more likely to be assigned to this team during a follow up hospitalization? Researchers will compare this to similar patients assigned to receive usual care. Some patient participants (or their caregivers) from both the PHP team and usual care groups will be asked to participate in interviews to help researchers understand the needs of patients who are frequently admitted and the care they receive.
Eligibility Criteria
Inclusion Criteria: * Age greater than 18 at the time of index admission * Two or more hospitalizations to a general medicine service at UW Health (University Hospital or East Madison Hospital) within the past 12 months AND an EPIC Readmission Risk Score of greater than a predetermined value Exclusion Criteria: * Outpatient primary care provider is part of the UW Health Family Medicine service that currently admits their own patients to a separate service at University Hospital * Patients with an oncologic diagnosis for which they are actively receiving chemotherapy or immunotherapy * Incarcerated persons * Pregnant women
Contact & Investigator
Sara Westergaard, MD, MPH
PRINCIPAL INVESTIGATOR
University of Wisconsin, Madison
Frequently Asked Questions
Who can join the NCT06581224 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying High-need, High-complexity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06581224 currently recruiting?
Yes, NCT06581224 is actively recruiting participants. Contact the research team at swesterga@medicine.wisc.edu for enrollment information.
Where is the NCT06581224 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT06581224 clinical trial?
NCT06581224 is sponsored by University of Wisconsin, Madison. The principal investigator is Sara Westergaard, MD, MPH at University of Wisconsin, Madison. The trial plans to enroll 1,200 participants.